Targeting Angiotensinogen With N-Acetylgalactosamine–Conjugated Small Interfering RNA to Reduce Blood Pressure

D Ye, EO Cruz-López, HC Tu, I Zlatev… - … , and Vascular Biology, 2023 - Am Heart Assoc
Blood pressure management involves antihypertensive therapies blocking the renin-
angiotensin system (RAS). Yet, it might be inadequate due to poor patient adherence or the …
被引用次数：2 相关文章
[HTML] nih.gov

[HTML][HTML] Targeting Angiotensinogen With N-Acetylgalactosamine–Conjugated Small Interfering RNA to Reduce Blood Pressure

D Ye, EO Cruz-López, HC Tu, I Zlatev… - … , and Vascular Biology, 2023 - ncbi.nlm.nih.gov
Blood pressure management involves antihypertensive therapies blocking the renin-
angiotensin system (RAS). Yet, it might be inadequate due to poor patient adherence or the …
[PDF] researchgate.net

[PDF][PDF] Targeting Angiotensinogen With N-Acetylgalactosamine–Conjugated Small Interfering RNA to Reduce Blood Pressure

D Ye, EO Cruz-López, HC Tu, I Zlatev… - … Thromb Vasc Biol, 2023 - researchgate.net
Blood pressure management involves antihypertensive therapies blocking the renin-
angiotensin system (RAS). Yet, it might be inadequate due to poor patient adherence or the …
[PDF] eur.nl

[PDF][PDF] Targeting Angiotensinogen With N-Acetylgalactosamine–Conjugated Small Interfering RNA to Reduce Blood Pressure

D Ye, EO Cruz-López, HC Tu, I Zlatev… - … Thromb Vasc Biol, 2023 - pure.eur.nl
Blood pressure management involves antihypertensive therapies blocking the renin-
angiotensin system (RAS). Yet, it might be inadequate due to poor patient adherence or the …

Targeting Angiotensinogen With N-Acetylgalactosamine-Conjugated Small Interfering RNA to Reduce Blood Pressure

D Ye, EO Cruz-López, HC Tu, I Zlatev… - … , and vascular biology - pubmed.ncbi.nlm.nih.gov
Blood pressure management involves antihypertensive therapies blocking the renin-
angiotensin system (RAS). Yet, it might be inadequate due to poor patient adherence or the …

Targeting Angiotensinogen With N-Acetylgalactosamine-Conjugated Small Interfering RNA to Reduce Blood Pressure.

D Ye, EO Cruz-López, HC Tu, I Zlatev… - … , and Vascular Biology, 2023 - europepmc.org
Blood pressure management involves antihypertensive therapies blocking the renin-
angiotensin system (RAS). Yet, it might be inadequate due to poor patient adherence or the …

Targeting Angiotensinogen With N-Acetylgalactosamine–Conjugated Small Interfering RNA to Reduce Blood Pressure

D Ye, EO Cruz-López, HC Tu, I Zlatev… - … and Vascular Biology, 2023 - ingentaconnect.com
Blood pressure management involves antihypertensive therapies blocking the renin-
angiotensin system (RAS). Yet, it might be inadequate due to poor patient adherence or the …